Browsing Tag
asciminib
2 posts
Why Enliven’s FDA alignment may matter as ELVN-001 moves toward Phase 3
Find out how Enliven’s ELVN-001 data and FDA alignment could reshape the next phase of chronic myeloid leukemia therapy.
Can asciminib reshape first-line CML treatment? Inside Scemblix’s rise as a new standard of care in Canada
More than a month after Health Canada’s approval, Scemblix is forcing a rethink of chronic myeloid leukemia therapy—and raising the bar for tolerability and precision.